According to Gartner,
“The fear, disruption and related hype in the COVID-19 era have prompted organizations to take an introspective look at their quality organizations to assess their existing solutions and needs. But astute observers have recognized that the basic fundamentals of quality management remain largely intact, despite changing priorities and solution requirements.”1
According to Ennov CEO Olivier Pâris,
“Ennov is honored to be recognized by Gartner in the 2020 Market Guide for Quality Management System Software. We have been providing our innovative QMS software to our clients for many years now and it is very rewarding to be recognized by such a well-respected source for our contributions to the industry.”
Positioned to address regulatory and FDA requirements, such as 21 CFR Part 11, Ennov’s QMS suite is built on its unified compliance platform which, in addition to quality management, also provides solutions for regulatory affairs, clinical trials and pharmacovigilance.
Ennov’s QMS functionality includes support for non-conformances & CAPAs, change controls, audits, deviations, claims and many other quality processes. Integrated document and learning management modules complete the software suite and provide a comprehensive solution to the most demanding QMS requirements.
Ennov’s QMS software is currently being used by over 80 Life Science companies worldwide.
1 – Gartner, “Market Guide for Quality Management System Software,”
Analysts: Sam New
Published: 9 November 2020
Headquartered in Paris, with offices in Raleigh, NC and Cambridge, UK, Ennov provides the most cost effective, comprehensive and user-friendly solutions for regulated content and process management for the Life Sciences industry. Our suite of software solutions is built on our unified compliance platform and is being used by over 150 Life Sciences companies and more than 250,00 users worldwide.